drugset / Trial / NCT01037985

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

NCT01037985 ↗

Phase 2 Completed 41 enrolled Pfizer
RandomizedDouble-blindTreatment

Summary

This study will compare how well EXC 001 works versus placebo in reducing the appearance of scars in subjects undergoing elective abdominoplasty. The study will also evaluate the safety of EXC 001 in healthy adult subjects.

Timeline

Start
2009-12-03
Primary completion
2010-07-07
Completion
2010-09-22

Outcome

Missed primary endpoint

registry p = 0.168; Mean Difference (Final Values) -4.3 (95% CI -10.4 to 1.9) NCT01037985 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject EXC 001 Unknown — Other

Indications